Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during ‘real-life’ glucose excursions
- 1 March 2010
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 27 (3) , 332-338
Abstract
To compare the accuracy of two marketed subcutaneous glucose monitoring devices (Guardian RT, GRT; GlucoDay S, GDS) and standard microdialysis (CMA60; MD) in Type 1 diabetic patients. Seven male Type diabetic patients were investigated over a period of 26 h simulating real-life meal glucose excursions. Catheters of the three systems were inserted into subcutaneous adipose tissue of the abdominal region. For MD, interstitial fluid was sampled at 30- to 60-min intervals for offline glucose determination. Reference samples were taken at 15- to 60-min intervals. All three systems were prospectively calibrated to reference. Median differences, median absolute relative differences (MARD), median absolute differences (MAD), Bland-Altman plot and Clark Error Grid were used to determine accuracy. Bland-Altman analysis indicated a mean glucose difference (2 standard deviations) between reference and interstitial glucose of -10.5 (41.8) % for GRT, 20.2 (55.9) % for GDS and 6.5 (35.2) % for MD, respectively. Overall MAD (interquartile range) was 1.07 (0.39; 2.04) mmol/l for GRT, 1.59 (0.54; 3.08) mmol/l for GDS and 0.76 (0.26; 1.58) mmol/l for MD. Overall MARD was 15.0 (5.6; 23.4) % (GRT), 19.7 (6.1; 37.6) % (GDS) and 8.7 (4.1; 18.3) % (MD), respectively. Total sensor failure occurred in two subjects using GRT and one subject using GDS. The three investigated technologies had comparable performance. Whereas GRT underestimated actual blood glucose, GDS and MD overestimated blood glucose. Considerable deviations during daily life meal glucose excursions from reference glucose were observed for all three investigated technologies. Present technologies may require further improvement until individual data can lead to direct and automated generation of therapeutic advice in diabetes management.Keywords
This publication has 28 references indexed in Scilit:
- The Accuracy of the Guardian ® RT Continuous Glucose Monitor in Children with Type 1 DiabetesDiabetes Technology & Therapeutics, 2008
- Alarms Based on Real-Time Sensor Glucose Values Alert Patients to Hypo- and Hyperglycemia: The Guardian Continuous Monitoring SystemDiabetes Technology & Therapeutics, 2004
- Clinical Performance of CGMS in Type 1 Diabetic Patients Treated by Continuous Subcutaneous Insulin Infusion Using Insulin AnalogsDiabetes Care, 2003
- Continuous Subcutaneous Glucose Monitoring in Diabetic PatientsDiabetes Care, 2002
- Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home UseDiabetes Technology & Therapeutics, 2000
- Metabolite levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flowAmerican Journal of Physiology-Endocrinology and Metabolism, 1998
- Microdialysis measurement of the absolute glucose concentration in subcutaneous adipose tissue allowing glucose monitoring in diabetic patientsDiabetologia, 1992
- Microdialysis—principles and applications for studies in animals and manJournal of Internal Medicine, 1991
- Characterization by microdialysis of intracellular glucose level in subcutaneous tissue in humansAmerican Journal of Physiology-Endocrinology and Metabolism, 1988
- A microdialysis method allowing characterization of intercellular water space in humansAmerican Journal of Physiology-Endocrinology and Metabolism, 1987